Artificial intelligence (AI) chatbots showed mixed results when it came to providing treatment strategies and direct-to-patient cancer advice for a variety of malignancies, according to 2 studies recently published in JAMA Oncology. Read More ›
A new report released by the American Cancer Society (ACS) shows that the incidence of colorectal cancer is rapidly increasing among younger individuals, and the disease is also being diagnosed at more advanced stages in people of all ages. Read More ›
An analysis from the ARASENS trial showed that the addition of darolutamide (Nubeqa) to androgen-deprivation therapy (ADT) and docetaxel significantly improved overall survival (OS) in subgroups of patients with metastatic hormone-sensitive prostate cancer (mHSPC) with high-volume and high-risk disease and should be considered the new standard of care for this patient population. Read More ›
The advent of biologic drugs has had a significant impact on the management of patients with cancer. However, the high costs associated with these agents can hinder treatment access for many patients and place a significant burden on healthcare systems. As several biologics have come off patent over the past few years and more are expected to do so in the near future, biosimilars are poised to play an increasingly important role in reducing healthcare costs. Read More ›
The Ohio-based company, PercuVision, LLC, developer of the telemedicine platform DirectVision DVS-III Telehealth Hub, and LocumTenens.com, a full-service healthcare staffing agency aligned with Georgia’s Jackson Healthcare network, have joined forces to launch a pilot program that will provide valuable clinical and emergency tele-urology services to patients across the United States. The goal of this new partnership is to improve access to care by extending urology services to urban and rural areas where there are few or no urologists, the 2 companies said in a recent press release. Read More ›
According to recent US census data, there are currently 18 million veterans living in the United States, and approximately 50% of these individuals are aged >65 years.1 In addition, the Veterans Affairs Central Cancer Registry reports that approximately 50,000 new cancer cases are reported each year among veterans.2 Many of these individuals, who live in remote locations, have significant mobility issues or are hesitant to travel to the nearest hospital for treatment. Recently, the Department of Veterans Affairs launched a novel program using telemedicine to overcome these obstacles and improve the quality of care for veterans with cancer. Read More ›
There is a growing recognition among payers and providers that social determinants of health—the social and socioeconomic factors that influence a patient’s care, such as income and access to transportation—are strongly linked to health outcomes. This recognition has been reinforced by a shift toward value-based payments, which incentivizes improved health outcomes rather than service delivery alone. Although it is evident that mitigating adverse social determinants can have a positive impact on patient outcomes and curb spending, results from a recent study reveal that Accountable Care Organizations (ACOs) face substantial challenges in integrating social services with patient care (Murray GF, et al. Health Aff (Millwood). 2020;39:199-206).